X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
Other Certificates
Other Suppliers
0
USA (Orange Book)
Europe
0
Canada
Australia
0
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
0
1. Compazine
2. Edisylate Salt, Prochlorperazine
3. Edisylate, Prochlorperazine
4. Maleate, Prochlorperazine
5. Prochlorperazine
6. Prochlorperazine Edisylate
7. Prochlorperazine Edisylate Salt
8. Salt, Prochlorperazine Edisylate
1. Prochlorperazine Dimaleate
2. 84-02-6
3. Prochlorperazine Dimaleate Salt
4. Buccastem
5. Vertigon
6. I1t8o1jtl6
7. Proclorperazine Maleate
8. Prochlorperazinu Dimaleat
9. Prochlorperazine Bimaleate
10. Prochlorperazine Hydrogen Maleate
11. Prochloroproazine Hydrogen Maleate
12. 10h-phenothiazine, 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)-, (z)-2-butenedioate (1:2)
13. Dsstox_cid_28941
14. Dsstox_rid_83206
15. Dsstox_gsid_49015
16. Emetiral
17. Pasotomin
18. Nibromin A
19. Meterazin Maleate
20. 2-chloro-10-[3[(4-methyl-1-piperazinyl)propyl]-10h-phenothiazine Dimaleate
21. Chebi:8436
22. Stemetil Dimaleate
23. 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine Dimaleate
24. 2-chloro-10-(3-(1-methyl-4-piperazinyl)propyl)phenothiazine, Dimaleate
25. 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine Maleate (1:2)
26. Cas-84-02-6
27. Sr-01000000260
28. Ncgc00015856-08
29. Mfcd00069330
30. Unii-i1t8o1jtl6
31. Prochlorperazine Maleate [jan]
32. Prochlorperazinu Dimaleat [czech]
33. Compazine (tn)
34. C20h24cln3s.2c4h4o4
35. Prestwick_410
36. Einecs 201-511-3
37. Prochlorperazine Maleate [usp:jan]
38. Prochlorperazin-dimaleat
39. Prochlorperazinedimaleate
40. 2-chloro-10-(3-(4-methylpiperazin-1-yl)propyl)-10h-phenothiazine Dimaleate
41. Prochlorperazine, Dimaleate
42. Schembl40755
43. Chembl1314751
44. Dtxsid1049015
45. Hms1569o19
46. Hms2096o19
47. Hms3263o09
48. Hms3713o19
49. Hms3885j12
50. Tox21_113522
51. Tox21_501034
52. S4631
53. Prochlorperazine Maleate (jp17/usp)
54. Akos024457528
55. Tox21_113522_1
56. Ccg-220399
57. Ccg-222338
58. Lp01034
59. Nsc 748866
60. Prochlorperazine Dimaleate [mi]
61. Prochlorperazine Maleate [mart.]
62. Prochlorperazine Maleate [vandf]
63. Ncgc00015856-10
64. Ncgc00094323-01
65. Ncgc00261719-01
66. Prochlorperazine Maleate [usp-rs]
67. Prochlorperazine Maleate [who-dd]
68. As-13744
69. Bp165885
70. Eu-0101034
71. P2368
72. Prochlorperazine Maleate [green Book]
73. Prochlorperazine Maleate [orange Book]
74. D00479
75. P 9178
76. Prochlorperazine Dimaleate [green Book]
77. Prochlorperazine Maleate [ep Monograph]
78. Prochlorperazine Maleate [usp Impurity]
79. Prochlorperazine Maleate [usp Monograph]
80. Sr-01000000260-2
81. Sr-01000000260-9
82. Q27108082
83. 2-chloro-10-[3-(4-methylpiperazin-1-yl)propyl]phenothiazine Dimaleate
84. Prochlorperazine Maleate, British Pharmacopoeia (bp) Reference Standard
85. Prochlorperazine Maleate, European Pharmacopoeia (ep) Reference Standard
86. 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)phenothiazine Maleate (1:2).
87. 2-chloro-10-[3[(4-methyl-1-piperazi Nyl)propyl]-10h-phenothiazine Dimaleate
88. Phenothiazine, 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)-, Maleate (1:2)
89. Prochlorperazine Maleate, United States Pharmacopeia (usp) Reference Standard
90. 10h-phenothiazine, 2-chloro-10-(3-(4-methyl-1-piperazinyl)propyl)-, (2z)-2-butenedioate (1:2)
| Molecular Weight | 606.1 g/mol |
|---|---|
| Molecular Formula | C28H32ClN3O8S |
| Hydrogen Bond Donor Count | 4 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 8 |
| Exact Mass | 605.1598639 g/mol |
| Monoisotopic Mass | 605.1598639 g/mol |
| Topological Polar Surface Area | 184 Ų |
| Heavy Atom Count | 41 |
| Formal Charge | 0 |
| Complexity | 548 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 2 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
| 1 of 1 | |
|---|---|
| Drug Name | Prochlorperazine maleate |
| Active Ingredient | Prochlorperazine maleate |
| Dosage Form | Tablet |
| Route | Oral |
| Strength | eq 5mg base; eq 10mg base |
| Market Status | Prescription |
| Company | Sandoz; Teva Pharms; Mylan |
Antiemetics
Drugs used to prevent NAUSEA or VOMITING. (See all compounds classified as Antiemetics.)
Dopamine Antagonists
Drugs that bind to but do not activate DOPAMINE RECEPTORS, thereby blocking the actions of dopamine or exogenous agonists. Many drugs used in the treatment of psychotic disorders (ANTIPSYCHOTIC AGENTS) are dopamine antagonists, although their therapeutic effects may be due to long-term adjustments of the brain rather than to the acute effects of blocking dopamine receptors. Dopamine antagonists have been used for several other clinical purposes including as ANTIEMETICS, in the treatment of Tourette syndrome, and for hiccup. Dopamine receptor blockade is associated with NEUROLEPTIC MALIGNANT SYNDROME. (See all compounds classified as Dopamine Antagonists.)
Antipsychotic Agents
Agents that control agitated psychotic behavior, alleviate acute psychotic states, reduce psychotic symptoms, and exert a quieting effect. They are used in SCHIZOPHRENIA; senile dementia; transient psychosis following surgery; or MYOCARDIAL INFARCTION; etc. These drugs are often referred to as neuroleptics alluding to the tendency to produce neurological side effects, but not all antipsychotics are likely to produce such effects. Many of these drugs may also be effective against nausea, emesis, and pruritus. (See all compounds classified as Antipsychotic Agents.)
Market Place
